Skip to content
Intended for US healthcare professionals.

Therapeutic area

Cardiovascular & vascular

1 article · 7 references

Colchicine and spironolactone after myocardial infarction: the factorial trial, the pooled evidence and the guideline's timing A 7,062-patient post-infarction trial found no reduction in its primary outcomes with colchicine (hazard ratio 0.99; 95% CI 0.85 to 1.16) or spironolactone, while a Cochrane review of 12 trials in cardiovascular disease found fewer infarctions and strokes with colchicine; the guideline's literature search closed before the trial reports. 4 min read · 7 references
Other therapeutic areas
Opioid-induced constipation 2 articlesAcute migraine 2 articlesAcute pain 2 articlesMusculoskeletal 3 articlesWomen's health & fertility 3 articlesOncology 3 articlesNephrology 1 articleEndocrinology & metabolism 1 articleMental & behavioral health 1 article
We use cookies on this site
We use essential cookies to make the site work, and — only with your consent — analytics cookies to see which clinical topics are read. See our Cookie Policy.
Manage preferences